Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × NETWORK × Giant Cell Tumor of Bone × Clear all

Phase

Status

Sponsor Class

OTHER 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 70 Lung Neoplasms 60 Breast Neoplasms 56 Lymphoma 51 Ovarian Neoplasms 44 Sarcoma 42 Leukemia 37 Prostatic Neoplasms 36 Multiple Myeloma 36 Central Nervous System Neoplasms 33 Head and Neck Neoplasms 32 Colorectal Neoplasms 30 Squamous Cell Carcinoma of Head and Neck 29 Rectal Neoplasms 28 Melanoma 28 Carcinoma, Ovarian Epithelial 28 Neoplasm Metastasis 26 Lymphoma, Large B-Cell, Diffuse 24 Urinary Bladder Neoplasms 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Leukemia, Lymphocytic, Chronic, B-Cell 23 Brain Neoplasms 23 Uterine Cervical Neoplasms 22 Endometrial Neoplasms 22 Adenocarcinoma of Lung 21 Leukemia, Myeloid, Acute 20 Glioblastoma 20 Fallopian Tube Neoplasms 20 Gliosarcoma 17 Lymphoma, Mantle-Cell 16

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03620149 2021-01-06

REDUCE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡